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780a Wednesday, February 19, 2014velocity and direction dependent on motor crowding and ionic strength but not
MT length. By contrast, truncated Cut7 monomers drive only plus end directed
MT sliding, indicating that plus end directed strokes are the basal activity of
the Cut7 motor head and that directional reversal is an emergent property of
interacting head-pairs. We propose a possible mechanism for directional
reversal, in which minus ended strokes are inhibited by motor crowding,
causing the basal plus end directed activity to dominate.
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The human kinesin-5 motor, Eg5, is required to establish and maintain the
mitotic spindle. We show that Src kinase binds to a unique motif in the
microtubule-binding interface of the Eg5 enzymatic head domain and phos-
phorylates three specific tyrosine residues in endogenous Eg5. These tyrosines
are located near the nucleotide pocket and the functionally critical Loop 5
region within the Eg5 head. We have also found that phosphomimetic Eg5
motor proteins have altered motility characteristics relative to wild-type and
non-phosphorylatable mutant proteins. Furthermore, cells expressing phospho-
mimetic Eg5 motors have increased spindle polarity defects. These results
implicate Eg5 as a potential direct mitotic target of tyrosine kinases, most
likely Src family kinases. Phosphomimetic motors also have greatly reduced
affinity for the Eg5 inhibitor S-trityl-L-cysteine (STLC). In cells with high
Src activity, including many types of cancers, the same mechanism may pro-
vide rapid resistance to therapy with Eg5 inhibitors.
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Kinesin-5 (Eg5) is an essential mitotic motor that couples ATP hydrolysis to
different protein-protein association states with microtubules. Human Eg5 is a
cancer chemotherapeutic target, having a unique allosteric site covered by
loop-5 (L5). This site is capable of binding small-molecule inhibitors with
> 100 different chemotypes. The prevailing biochemical model is that all
L5-directed drugs inhibit ADP release, but it does not address the 107-fold
difference in potency or the lack of chemical homology between inhibitor
families. An alternative hypothesis is that the inhibitors act on different
catalytic intermediates, which gives rise to their disparate potencies. Here
we present our linear free energy relationship (LFER) study of Eg5, a method
to determine whether an inhibitor can block the catalytic transition-state.
Steady-state kinetic parameters for wildtype Eg5 and eight different L5
mutants were determined in the background of three different L5-directed
inhibitors and a mock control. The predominant effect of the L5 residue sub-
stitution is alteration of substrate binding (Km), whereas principal outcome of
allosteric drug is change in ATP hydrolysis (kcat). Second, our data showed
that despite their use of the same binding pocket, one compound can inhibit
the transition state and the other two do not. We conclude that the drugs are
not synonymous: it is possible for one allosteric modulator to regulate ADP
release and another to control transition-state formation. The significance
is that this is the first demonstration of allosteric control of more than one
catalytic intermediate for any drug target. Furthermore, these results may
give insight into the disparity between increased inhibitor potency and success
in clinical trials.
This work is funded by the support of the National Institutes of Health (R01
GM097350; S.K.) and the LSU School of Graduate Studies (M.L.).
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The kinesin Eg5, is a microtubule plus-end directed homotetrameric molecular
motor that is essential for the formation of a bipolar spindle during eukaryotic
cell division. Eg5 exists only in proliferating cells, and is required for mitosis.
Therefore, Eg5 is new target of cancer therapy. It is known that some small
molecules specifically inhibit Eg5 activity. S-trityl-L-cysteine (STLC) is one
of the potent Eg5 specific inhibitors. In this study, we tried to develop photo-chromic Eg5 inhibitors that control inhibitory activity of Eg5 by ultraviolet
(UV) and visible (VIS) light irradiations reversibly. Azobenzene is one of
the typical photochromic molecules, which shows cis, and trans isomerization
by UV and VIS light irradiations respectively. In this study, we designed
and synthesized photochromic inhibitors utilizing azobenzene. As the trityl
group of STLC is a key moiety to exhibit inhibitory activity, we linked
the trityl group to N-acetyl cysteine or maleic acid via azobenzene. The syn-
thesized two photochromic inhibitors, TAB-MA and TAB-Ac-Cys inhibited
the ATPase activity of Eg5 at the different inhibition constants between cis
and trans isomers. Trans-isomers of the inhibitors showed more significant
inhibition of ATPase activity than cis-isomers. Moreover, Eg5 driven microtu-
bule gliding was photo controlled by TAB-Ac-Cys. Trans-TAB-Ac-Cys
decreased the velocity of microtubule gliding more significantly than cis-
TAB-Ac-Cys.
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The mitotic kinesin Eg5 has an important role in establishing the bipolar spin-
dle which is directly involved in the cell division. Recently, several small
molecules have been identified as potent specific inhibitor of Eg5. STLC is
one of the inhibitor which does not compete with either ATP or microtubules
but slows down ADP release. STLC binds to the pocket on Eg5 composed
by a2, a3 and loop L5. STLC binding induces the downward swing of L5 to
close the inhibitor binding pocket. Therefore, L5 is one of the key region to
stabilize Eg5-STLC complex. Previously, we incorporated photochromic
molecules into L5 to photo-control inhibitory activity of STLC. Successfully
Eg5 mutant D130C modified with spiropyran derivative showed significant
photo-reversible resistance to STLC.
In this study, further application of photochromic molecules to regulate Eg5
activity was performed. We synthesized photochromic STLC analogue,
IASP-L-Cys composed of spiropyran and L-cystein to regulate Eg5 ATPase
and motor activity reversibly upon ultraviolet and visible lights irradiation.
IASP-L-Cys exhibited merocyanine - spiro isomerization upon ultraviolet
and visible light irradiations. Zwitterionic merocyanine isomer has a
ring-opening structure and differs from the other isomer of spiro that is hydro-
phobic and ring-closing structure. Therefore, it is expected that photo-
isomerization of IASP-L-Cys may alter its inhibitory activity for Eg5
significantly. Microtubule dependent ATPase activity of Eg5 was inhibited
by IASP-L-Cys in a concentration dependent manner. And the inhibitory ac-
tivity of IASP-L-Cys for Eg5 was drastically changed correlating to photo-
isomerization. Merocyanine isomer showed much higher inhibition constant
than that of spiro isomer (approximately 20 mM and 100 mM, respectively).
We also examined the effect of phtoisomerization of IASP-L-Cys for the
cell mitosis using HeLa cell.
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Motor proteins coordinate the activities of nucleotide hydrolysis and polymer
binding to move along cellular tracks. In kinesin and myosin motor domains,
the sites responsible for these two activities are located on opposite faces of a
core beta-sheet. Three beta-strands and a mobile loop transduce information
between the active and polymer-binding sites and, thus, are collectively
termed the transducer. Herein we demonstrate residues in the core beta-
sheet and the L5 loop are thermodynamically coupled. Two methods were
employed in this study. Probabilistic methods to analyze evolutionarily cor-
relations between residues in protein families identified coupling between
transducer residues. Second, thermodynamic linkage between M115 in
loop-5 and L263 in beta-7 in the human kinesin-5 motor domain was estab-
lished using double mutant cycle analysis for wildtype, two single mutants,
and the corresponding double mutant protein. The resulting changes in free
energy were calculated from experimentally measured kinetic parameters
and determined to be non-additive. While conformational changes of
the beta strands and mobile loop have been observed in structural investiga-
tions of kinesins and myosins, these experiments establish energetic and
evolutionary coupling of these distinct motifs. We conclude that loop-5
